Inventor · disambiguated record
Jean E. Lachowicz
Also filed as: LACHOWICZ JEAN E
5 granted patents·4 pending applications·11 citations·filing 2001–2009
72Inventor score
Top patents by PatentIndex Score
9 records- 0184US7572802B27-[2-[4-(6-fluoro-3-methyl-1,2-benzisoxazol-5-yl)-1-piperazinyl]ethyl]-2-(1-propynyl)-7H-pyrazolo-[4,3-e]-[1,2,4]-triazolo-[1,5-C]-pyrimidin-5-amineSCHERING CORP·Filed 2006·Granted Aug 11, 2009·7 cites·15 claims
- 0275US8389532B27-[2-[4-(6-fluoro-3-methyl-1,2-benzisoxazol-5-yl)-1-piperazinyl]ethyl]-2-(1-propynyl)-7H-pyrazolo-[4,3-E]-[1,2,4]-triazolo-[1,5-C]-pyrimidin-5-amineBOYLE CRAIG D·Filed 2009·Granted Mar 5, 2013·2 cites·4 claims
- 0370US7157244B2Adenosine receptorSCHERING CORP·Filed 2001·Granted Jan 2, 2007·2 cites·28 claims
- 0459US7465789B2Adenosine receptorSCHERING CORP·Filed 2006·Granted Dec 16, 2008·0 cites·4 claims
- 0547US2010144591A1Benzimidazole derivatives and methods of use thereofSCHERING CORP·Filed 2008·Application pending·0 cites
- 0646US2010093692A1Piperidinyl-piperidine and piperazinyl-piperidine for use in the treatment of diabetes or painSCHERING CORP SECHERING PLOUGH·Filed 2008·Application pending·0 cites
- 0746US2007219154A1Methods for preventing and/or treating a cell proliferative disorderLIU SUXING·Filed 2006·Application pending·0 cites
- 0845US7423149B2Substituted n-aryl amidines as selective D1 dopamine receptor antagonists for the treatment of obesity and CNS disordersSCHERING CORP·Filed 2004·Granted Sep 9, 2008·0 cites·7 claims
- 0942US2007142369A1Combination of an H3 antagonist/inverse agonist and an appetite suppressantVAN HEEK MARGARET·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jean E. Lachowicz files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →